K. Sainio et al., ANTISENSE INHIBITION OF LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR IN KIDNEY CULTURES - POWER AND PITFALLS, Cellular and molecular neurobiology, 14(5), 1994, pp. 439-457
1. Antisense inhibition of gene expression implies that the expression
of the target protein is selectively inhibited at either the translat
ional or the transcriptional level by complementary DNA or RNA constru
cts that are antiparallel to the target sequence. The antisense inhibi
tion strategy provides means to study the roles of individual proteins
and has, in spite of its limitations, gained a wide range of both the
rapeutic and experimental applications, 2. In developmental biology, p
rotein expression has been selectively inhibited by the use of antisen
se gene transfection and by antisense deoxyoligonucleotides, The trans
fectability of embryonic tissues is variable, but in general fetal and
embryonic cells take up foreign DNA relatively efficiently, in partic
ular, short deoxyoligonucleotides that penetrate mesenchymal cells wit
hin a few hours without any manipulation. 3. We have now evaluated the
advantages and pitfalls of antisense inhibition by deoxyoligonucleoti
des in organ culture and describe our experience from the inhibition o
f low-affinity nerve growth factor receptor expression in embryonic mo
use and rat kidneys. 4. The expression of nerve growth factor receptor
can be specifically inhibited by deoxyoligonucleotides, but the targe
t sequence-dependent window of, in particular, phosphorothioate-modifi
ed oligonucleotides is quite narrow. The culture conditions affect the
response to the oligonucleotides and their cellular incorporation is
variable with respect to the cell type and stage of differentiation.